NCT01015638 - Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin and BPO 5% gel

Once-daily applications, to the randomized side of the face either left or right, of clindamycin and benzoyl peroxide (BPO) 5% gel.

DRUG

Clindamycin phosphate and benzoyl peroxide 2.5% gel.

Once daily application of clindamycin phosphate and benzoyl peroxide (BPO) 2.5% gel

Trial Locations (1)

cyberDERM, Broomall